Reproductive options for female cancer patients: Balancing hope and realistic expectation

Current Opinion in Oncology

Volumn 26, Issue 5, 2014, Pages 501-507

  Lavery, Stuart ^a   Tsiligiannis, Sophia ^b   Das, Mausumi ^a   Trew, Geoffery ^a   Carby, Anna ^c  

^a IVF Hammersmith   (United Kingdom)

^b QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^c Boston Palace Clinic   (United Kingdom)

Author keywords

fertility preservation; oncofertility; vitrification reproductive options for cancer patients

Indexed keywords

GONADORELIN;

AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; HUMAN; OOCYTE; OVARY; PRIORITY JOURNAL; REPRODUCTION; REVIEW; VITRIFICATION; NEOPLASM; PATHOLOGY; PROCEDURES;

CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; HUMANS; NEOPLASMS; OOCYTES; OVARY;

EID: 84906098554     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0000000000000105     Document Type: Review

References (30)

1. Meirow D, Biederman H, Anderson R, et al. Toxicity of chemotherapy and radiation on female reproduction. Clin Obs Gyn 2010; 53: 727-739
2. Wallace WHB, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod 2003; 18: 117-121
3. Wilkes S, Coulson S, Crosland A, et al. Experience of fertility preservation among younger people diagnosed with cancer. Hum Fertil (Camb) 2010; 13: 151-158
4. Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 2000; 342: 1919
5. Donnez J, Silber S, Andersen CY. Children born after autotransplantation of cryopreserved ovarian tissue: A review of 13 live births. Ann Med 2011; 43: 437-450
6. Schmidt KT, Resendahl M, Ernst E. Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure: The Danish experience. Fertil Steril 2011; 95: 695-701
7. Brydoy M, Fossa SD, Dahl O. Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncol 2007; 46: 480-489
8. Grifo JA, Noyes N. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: Potential fertility preservation for female cancer patients. Fertil Steril 2010; 93: 391-396
9. Shaw JM, Oranratnachai A, Trounson AO. Fundamental cryobiology of mammalian oocytes and ovarian tissue. Theriogenology 2000; 53: 59-72
10. Cobo A, Domingo J, Pé rez S, et al. Vitrification: An effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol 2008; 10: 268-273
11. Sönmezer M, Türkçüoǧlu I, Coşkun U, Oktay K. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril 2011; 95: 2125
12. Cobo A, Kuwayama M, Pé rez S, et al. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril 2008; 89: 1657-1664
13. Rodriguez-Wallberg KA, Oktay K. Recent advances in oocyte and ovarian tissue cryopreservation and transplantation. Best Pract Res Clin Obstet Gynaecol 2012; 26: 391-405
14. Oktay K, Türkçüoǧlu I, Rodriguez-Wallberg KA. Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: What is the explanation? Fertil Steril 2011; 95: 804
15. Kim SS, Radford J, Harris M, et al. Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Hum Reprod 2001; 16: 2056-2060
16. Greve T, Wielenga VT, Grauslund M, et al. Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination. Eur J Cancer 2013; 49: 1932-1938
17. Wallace WH, Kelsey TW, Anderson RA. Ovarian cryopreservation: Experimental or established and a cure for the menopause? Reprod Biomed Online 2012; 25: 93-95
18. Kim SS. Ovarian tissue banking for cancer patients: To do or not to do? Hum Reprod 2003; 18: 1759-1761
19. Lutchman SK, Davies M, Chatterjee R. Fertility in female cancer survivors: Pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update 2005; 11: 69-89
20. Pfeifer S, Coutifaris C. Reproductive technologies 1998: Options available for the cancer patient. Med Pediatr Oncol 1999; 33: 34-40
21. Hovatta O. Mature eggs from primordial follicles in vitro: A challenge in the near future. Duodecim 2012; 128: 889-894
22. Veeck LL, Bodine R, Clarke RN, et al. High pregnancy rates can be achieved after freezing and thawing human blastocysts. Fertil Steril 2004; 82: 1418-1427
23. Rodriguez-Wallberg KA, Oktay K. Review Fertility preservation in women with breast cancer. Clin Obstet Gynecol 2010; 53: 753-762
24. Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: A prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005; 23: 4347-4353
25. Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol 2005; 23: 3858-3859
26. Oktay K, Lee S, Kim JY, et al. Long-Term outcomes and safety of letrozole-FSH protocol in women with breast cancer undergoing fertility preservation: A prospective-controlled study. Fertil Steril 2010; 94 (4 Suppl 1): S11
27. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24: 2917-2931
28. Ataya K, Rao LV, Lawrence E, et al. Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 1995; 52: 365-372
29. Badawy A, Elnashar A, El-Ashry M, et al. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: Prospective randomized study. Fertil Steril 2009; 91: 694-697
30. Chen H, Li J, Cui T, et al. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev 2011; CD008018. doi: 10.1002/14651858.CD008018.pub2